wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33904455-DECB736B-D046-4363-BCB9-890E07DA3B0B
Q33904455-DECB736B-D046-4363-BCB9-890E07DA3B0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33904455-DECB736B-D046-4363-BCB9-890E07DA3B0B
PCSK9 inhibitors - from discovery of a single mutation to a groundbreaking therapy of lipid disorders in one decade.
P2860
Q33904455-DECB736B-D046-4363-BCB9-890E07DA3B0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33904455-DECB736B-D046-4363-BCB9-890E07DA3B0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
536b8960c3f5124ae390eebe0e5a385855d8aff1
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.